NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/28/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization10.89 mln
Float1.43 mln
Earnings Date11/05/2026
Piotroski F-Score
3
/ 9
Below average
Relative Strength
96
/ 100
Top performer
Debt / Equity
0.00
Debt-free
ROE
-291
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Quoin Pharmaceuticals is a specialty drug company based in Ashburn, Virginia, focused on developing treatments for rare and serious skin conditions such as Netherton Syndrome, epidermolysis bullosa, and scleroderma. Its lead product, QRX003, is a topical lotion currently in late-stage development, with several other treatments also in progress. Founded in 2018 as a subsidiary of Skinvisible Inc., the company works alongside a number of research and consulting partners to advance its pipeline toward commercialization in the United States.
